Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9313.84 | 1444 / 1445 | 100% | 216.76 | 183 / 183 |
breast | 100% | 11605.97 | 458 / 459 | 100% | 246.69 | 1116 / 1118 |
intestine | 100% | 8099.77 | 964 / 966 | 100% | 203.02 | 526 / 527 |
brain | 99% | 29193.67 | 2627 / 2642 | 100% | 335.31 | 705 / 705 |
bladder | 100% | 9719.14 | 21 / 21 | 99% | 212.78 | 501 / 504 |
skin | 100% | 10382.21 | 1802 / 1809 | 100% | 280.54 | 471 / 472 |
kidney | 100% | 6742.78 | 89 / 89 | 99% | 185.80 | 894 / 901 |
uterus | 99% | 8269.04 | 169 / 170 | 100% | 219.08 | 458 / 459 |
adrenal gland | 100% | 16067.94 | 258 / 258 | 99% | 298.84 | 228 / 230 |
lung | 99% | 8977.11 | 571 / 578 | 100% | 265.96 | 1155 / 1155 |
prostate | 99% | 6977.58 | 242 / 245 | 100% | 198.85 | 501 / 502 |
ovary | 99% | 6844.65 | 178 / 180 | 100% | 127.11 | 428 / 430 |
thymus | 99% | 6025.98 | 644 / 653 | 98% | 98.50 | 590 / 605 |
stomach | 84% | 5476.64 | 303 / 359 | 100% | 181.27 | 286 / 286 |
liver | 84% | 4502.33 | 190 / 226 | 98% | 118.64 | 396 / 406 |
pancreas | 69% | 2949.70 | 226 / 328 | 99% | 189.40 | 176 / 178 |
adipose | 100% | 15939.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 184.16 | 29 / 29 |
muscle | 100% | 28574.06 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 218.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 104.57 | 1 / 1 |
blood vessel | 100% | 10291.31 | 1331 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 6324.04 | 240 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 134.52 | 78 / 80 |
heart | 95% | 13027.63 | 817 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 50% | 5209.71 | 461 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045664 | Biological process | regulation of neuron differentiation |
GO_0009966 | Biological process | regulation of signal transduction |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0006605 | Biological process | protein targeting |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0008104 | Biological process | protein localization |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0098793 | Cellular component | presynapse |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0005159 | Molecular function | insulin-like growth factor receptor binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0140031 | Molecular function | phosphorylation-dependent protein binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0008426 | Molecular function | protein kinase C inhibitor activity |
Gene name | YWHAG |
Protein name | 14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed] |
Synonyms | |
Description | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways . Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif . Binding generally results in the modulation of the activity of the binding partner . Promotes inactivation of WDR24 component of the GATOR2 complex by binding to phosphorylated WDR24 . . |
Accessions | ENST00000307630.5 P61981 |